EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Editorial: IgA and mucosal immunity in vaccinology and in protection from infection

Rita Carsetti, Isabella Quinti

Frontiers in Cellular and Infection Microbiology · 10.04.2024 · 14

DOI: 10.3389/fcimb.2024.1409111 ↗

Kurz gefasst

Editorial in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 10.04.2024. Verfasst von Rita Carsetti und 1 weiteren Autor:innen. Beteiligte Einrichtung: B Cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Immunity, Mucosal, Immunoglobulin A. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Editorial on the Research TopicIgA and mucosal immunity in vaccinology and in protection from infection Specific and neutralizing antibody titers are considered the best correlates of protection after vaccination or infection.The concentration of serum antibodies of both IgG and IgA isotypes, however, does not reflect mucosal immunity.IgA is the most abundant antibody at mucosal sites and can be detected in various biological specimens, including saliva, tears, and breast milk.The Research Topic aims to better define the IgA response to immunization in the serum and at mucosal sites.Infection and/or vaccination induce the production of protective antibodies of IgG isotype in the serum.These antibodies have a high affinity for the stimulating antigen and bind and neutralize pathogens, but do not prevent infection at mucosal sites.Several vaccines against SARS-CoV-2 have been approved for use all over the world.Whereas in Western countries, mRNA and adenovirus-based products were administered to the large majority of the population, the inactivated vaccine BBIBP-CorV was widely used in China.Similar to all other vaccines, also two doses of BBIBP-CorV induced a strong immune response which declined three months later.A booster dose increased antibody levels and affinity (Wu et al.).Although all vaccines, including BBIBP-CorV, protect from hospitalization and severe disease, infection and reinfection remain unstoppable.The question of whether systemically administered vaccines can guarantee protection at the site of viral entry and induce IgA production is still open.There is limited knowledge on the affinity, neutralizing activity, and longevity of mucosal IgA.We cannot measure to what extent vaccines administered intramuscularly contribute to immune protection at mucosal sites.These questions have been prioritized by the COVID-19 experience that has demonstrated the inability of effective vaccines and also hybrid immunity to prevent infection.Two papers in this Research Topic address the role of mucosal immunity to SARS-Cov-2.Stolovich-Ran et al. show that after intramuscular administration of mRNA vaccines, high levels of neutralizing IgG antibodies can be detected in the serum, whereas the increase of IgA is variable and transient.Most importantly, vaccine-induced IgA is monomeric and devoid of neutralizing ability.In contrast, IgA in the saliva, although produced in quantities that are equally variable and transient, is of the secretory type, i.e. polymeric, and can neutralize the virus.Injectable vaccines administered to naïve individuals did not induce

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, MucosalImmunoglobulin AHumansVaccinologyVaccinesAnimalsVaccination

Stichwörter der Autor:innen

IgAimmunizationmilkmucosal immunityprotection

Substanzen

Immunoglobulin AVaccines

Autor:innen und Institutionen

  • B Cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Zitieren

APA

Carsetti, R., & Quinti, I. (2024). Editorial: IgA and mucosal immunity in vaccinology and in protection from infection. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1409111

Vancouver

Carsetti R, Quinti I. Editorial: IgA and mucosal immunity in vaccinology and in protection from infection. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1409111

BibTeX
@article{Carsetti2024,
  author = {Carsetti, Rita and Quinti, Isabella},
  title = {Editorial: IgA and mucosal immunity in vaccinology and in protection from infection},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1409111}
}
Kostenlos starten →